BREYANZI
Analogs of BREYANZI
Find cheaper analogs and generic equivalents for BREYANZI.
Active Ingredient: LISOCABTAGENE MARALEUCEL
Product Overview
About BREYANZI
BREYANZI is a prescription medicine used to treat adult patients with relapsed or refractory follicular lymphoma after at least two prior therapies.
Key Benefits & Uses
- Treatment of relapsed or refractory follicular lymphoma
- Used in adult patients after at least two prior therapies
Active Ingredient & Action
BREYANZI contains the active ingredient lisocabtagene maraleucel, a CD19-directed CAR T cell therapy. It works by using a patient's own T cells to recognize and attack cancer cells expressing the CD19 protein.
Important Notes
It is essential to discuss the potential benefits and risks of BREYANZI with your healthcare provider before starting treatment. BREYANZI can cause serious side effects, including cytokine release syndrome (CRS), neurologic toxicities, and infections. Your healthcare provider will monitor you for these and other potential side effects during and after treatment.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.